Background: Several studies have shown that the presence of cerebrovascular lesions may play an important role for determining the severity of the clinical symptoms of dementia. But no study to date has explored the clinical effect of cerebrovascular disease in Parkinson's disease with dementia (PDD), although cerebrovascular disease is common causes of dementia in elderly population. Therefore we conducted this study to evaluate the relationship between silent cerebrovascular lesions and cognitive decline in PDD. Methods: Only 27 patients with PDD were chosen; 17 patients had PDD with silent cerebral ischemic lesions (PDDI) and 10 patients had PDD without silent cerebral ischemic lesions (pure PDD). These subjects received the global cognitive function testing and were all evaluated with detailed neuropsychological tests including attention, memory, language, and also the visuospatial and frontal function. Results: There were no significant differences between pure PDD and PDDI group on general cognitive functions tests. Regard to mean time duration of suffering from Parkinson motor symptoms and motor function scale, pure PDD group showed more long duration than PDDI group but there was no significant difference between two groups. Furthermore, there were not any significant differences between the two groups on detailed neuropsychological tests. Conclusions: we concluded that silent cerebrovascular lesions do not contribute to neuropsychological severity of PDD, although vascular disease is a common cause of cognitive impairment in the elderly. Thus the results of the present study suggest that factors other than cerebrovascular disease contribute to severity of PDD.
INTRODUCTION
Although most of patients with idiopathic Parkinson' s disease (PD) have circumscribed cognitive impairment, only a proportion of them develop dementia [1] . The etiology of dementia in PD remains unknown yet. Cortical changes, including concomitant Alzheimer disease (AD) pathology, Lewy bodies, and frontal atrophy, may be involved in PD with dementia (PDD) [2, 3] . Subcortical pathologies, which may contribute to dementia in PD, include atrophy of the cholinergic nucleus basalis of Meynert, striatonigral degeneration, and involvement of the dopaminergic ventral tegmental area and other monoaminergic nuclei [3] . Cerebrovascular lesions are common in older persons and they are generally considered to be among the most common causes of dementia. Recently several studies have shown that the presence of cerebrovascular lesions may play an important role for determining the presence and severity of the clinical symptoms of AD, for lowering the threshold of the AD pathology that' s required for the clinical expression of dementia [4, 5] . And cerebrovascular pathologies frequently coexist with AD and this combination may show synergistic effects on patients' cognitive decline, yet the results of the epidemiologic and clinico-pathologic studies on the relation between cerebrovascular disease and AD have been controversial [6] .
In regard to PDD, no study to date has explored the clinical http://dx.doi.org/10.12779/dnd.2013.12.3.72 www.dementia.or.kr effect of cerebrovascular disease in patients with PDD, although cerebrovascular disease is most common causes of dementia as well as common disease in elderly population.
Therefore we conducted this study to evaluate the clinical relationship between silent cerebral ischemic lesions and cognitive decline in patient with PDD.
METHODS

Subjects
The study was approved by the local ethics committee and each patient gave written informed consent for participation.
We prospectively included all consecutive PD patients with complaints of memory disturbance, who presented to demen- any signs of atypical parkinsonism and those patients who fulfilled the DSM-IV criteria for delirium or amnesic disorders and depressive disorders [9, 10] . Apart from the above mentioned exclusion criteria, we excluded patients with secondary causes of parkinsonism that would, in judgment of the investigators, interfere with the safe conduct of the study.
We defined silent cerebral ischemic lesions as evidence on the brain MRI of one or more ischemic lesions, without a history of a stroke or transient ischemic attack and neurological symptoms. If a prior stroke or transient ischemic attack did correspond with a lesion, we excluded the patients with these lesions from this study. All of the PDDI had few small ischemic white matter lesions with the exception of the sites of strategic infarction dementia. The lesions included in this study were defined as the size of the deep white matter and periventricular white matter lesions (extending cap or irregular halo) that were less than 10 mm, and the lacunar lesions had less than 5 lesion sites, but we excluded lesions involving medial and lateral cholinergic pathway and diffusely confluent hyperintensities (> 25 mm, irregular shape) of white matter in this study [11] [12] [13] . These criteria were mainly based on brain imaging criteria for subcortical vascular dementia by Erkinjuntti et al. [11] .
We also assessed stroke risk factors, such as hypertension, cigarette smoking, hypercholesterolemia, diabetes mellitus and heart diseases, by evaluating the patients' medical histories and laboratory findings to examine association of these factors between PDD and PDDI group. Test: word reading and color reading) [16] [17] [18] .
Data analysis
The statistical analysis was performed with the SPSS soft- 
RESULT
The number of subjects, the mean age, length of education, is one domain out of cognitive domains that characterized in patients with PDD, also showed no significant differences between the two groups.
With regard to association of risk factors for ischemic lesions including hypertension, diabetes mellitus, cholesterol, cigarette smoking and heart disease, there was no significant association between pure PDD and PDDI (Table 4) .
Multiple linear regression analysis showed that MMSE and CDR scores, which indicate the severity of cognitive decline, 
DISCUSSION
In the present pilot study, we investigated the characteristics of the cognitive profiles of patients with pure PDD and PDDI. And we attempted to clarify the influence of silent cerebral ischemic lesions on cognition on patients with PDD by using comprehensive neuropsychological tests. However, although previous studies suggested significant association between AD and cerebrovascular lesions [4, 19] , we cannot find out sharp neuropsychological differences between patients with pure PDD and PDDI.
Generally, it is known that cerebrovascular disease is second most common cause of dementia and it has also has been suggested that AD may be primarily a vascular disorder [20, 21] . Previous study also reported that AD with cerebrovascular disease showed more severe cognitive decline than AD without cerebrovascular disease, indicating cerebrovascular disease contributes to the severity of cognitive decline [19] . Moreover, Ronchi et al. suggested that stroke is a strong risk factor for dementia and the hypothesis that a stroke event may near the beginning of dementia by about 10 years, possibly accelerating the progression from cognitive impairment/ no dementia to dementia [22] . The Framingham study also demonstrated that stroke increased the risk of dementia 2.6 times in subjects aged up to 80 years, and 2.4 times in subjects who had completed high school [23] . However, few studies have examined the role of cerebrovascular risk factors for dementia in PD. A study by Salganik et al. [24] showed correlation between hypertension and dementia in a convenience sample of PD patients. But the authors found out no definite correlation between cerebrovascular disease or cardiovascular disease and dementia in these subjects [24] . Furthermore, recent large cohort study by Haugarvoll et al. [25] concluded that cerebrovascular risk factors do not contribute to dementia in patients with PD. In recent clinicopathological study on 97 PD brain donors, Papapetropoulos et al. [26] also reported that there was no association between ischemic cerebrovascular disease and specific phenotypic characteristics of PD including dementia. There are several potential factors contributed to PDD, such as advanced age, depression, presence of speech and axial involvement et al. [27] . Although the relative contribution of each of these factors is not known, previous several studies suggest that cortical Lewy bodies is the most important cause of PDD [25, 28, 29] . In accordance with above-mentioned several previous studies, we might also conclude that cerebral ischemic lesions do not contribute to neuropsychological severity of PDD in the current study, although vascular disease is a common cause of cognitive impairment and dementia in the elderly [25] . Thus this finding could also suggest that factors other than cerebrovascular disease contribute to severity of PDD. Furthermore this conclusion is consistent with the finding that cerebrovascular disease is rare in patients with dementia with Lewy bodies [30] .
This study had several limitations. First, this study was not large-scale longitudinal study and second, this study was the use of PDD diagnostic criteria that have not yet been validated. And differentiating between PDD and dementia with Lewy bodies on the basis of clinical criteria is difficult. Additionally, we cannot be certain about the accuracy of our clinical diagnosis because of the lack of the neuropathologic confirmation, because the patients were still alive. The major strength of this study is that comprehensive neuropsychological tests for dementia features and neurological examination for parkinsonian features were performed on all of the PDD patients by experts in each clinic.
In conclusion, the result of the present study suggested that silent cerebral ischemic lesions were not contributed to neuropsychological severity of PDD, indicating that the PD-related degenerative brain changes are the main causes of dementia in PD. We could also think that PDD is less influenced by a reduction of the cognitive reserve induced by cerebrovascular lesions without cholinergic pathway involvement than AD and vascular dementia. However, to clarify this assumption, clinicopathologic studies and studies using magnetic resonance imaging, involving large cohort of PD patients, are needed to further explore the relative contribution of vascular and neurodegnenrative factors on PDD.
